THE USE OF INTRAVENOUS LASER BLOOD IRRADIATION IN THE TREATMENT OF PATIENTS WITH BEHCET’S SYNDROME

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract


The results of a microbiological and PCR survey of patients with Behcet’s disease, as well as the results of intravenous laser irradiation of the blood (ILIB) are presented. According to the authors, the clinical picture of the disease was represented by the presence of single and multiple repeatedly recurring erosive and ulcerative defects in the area of the oral mucosa (cheek area and lateral surface of the tongue) and/or external genitalia. 4 patients noted soreness in the area of rashes, in 2 rashes were accompanied by a rise in temperature and the symptoms of malaise, weakness. Signs of catarrhal conjunctivitis and uveitis were present in 3 patients, while there was no reduction in visual acuity in the course of the disease. 3 patients had pain in large joints without visible changes on the radiograph and an increase in ESR up to 18-24 mm/h. As a result of the complex therapy with antibacterial, antiprotozoal, antiviral, antifungal therapy depending on the detected pathogen, as well as procedures of ILIB, the resorption of the infiltration zone was noted on the 10-11th day of treatment. Ulcerative elements began to epithelize. Erythema, feelings of burning and pain were absent.

Full Text

Restricted Access

About the authors

D. F Porsokhonova

Republican Specialized Scientific and Practical Medical Center for Dermatovenereology and Cosmetology

Tashkent, 100109, Republic of Uzbekistan

V. S Novoselov

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Moscow, 119991, Russian Federation

A. I Yakubovich

Irkutsk State Medical University

Irkutsk, 664003, Russian Federation

M. A Mirsaidova

Republican Specialized Scientific and Practical Medical Center for Dermatovenereology and Cosmetology

Tashkent, 100109, Republic of Uzbekistan

Yu. N Radzhabova

Republican Specialized Scientific and Practical Medical Center for Dermatovenereology and Cosmetology

Tashkent, 100109, Republic of Uzbekistan

Ivan S. Maximov

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: maximov.is@mail.ru
Moscow, 119991, Russian Federation
assistant of the Department of Dermatology and Venereology, I.M. Sechenov First Moscow State Medical University, Moscow, 119991, Russian Federation

References

  1. Абидов А.М., Исамухамедова Н.Р., Меджитова А.М. Клинический случай болезни Бехчета. Дерматовенерология и эстетическая медицина. 2014; 22(2): 74-8. https://dermatology.uz/images/jurnal/2014/new-133_DERMATOLOGIYA_No.2_2014.pdf
  2. Lee J.H., Lee C.S., Lee S.C. Interferon alpha-2a treatment for refractory Behcet uveitis in Korean patients. BMC Ophthalmol. 2018; 18(1): 52.
  3. Кисина В.И, Михалко О.Е., Мерзабекова М.А., Полищук Н.А. Роль бактерий и вирусов в патогенезе фоновых и диспластических процессов слизистой оболочки шейки матки и влагалища. Вестник дерматологии и венерологии. 2001; (2): 40-5.
  4. Манищенкова Ю.А., Коломиец В.И., Некрасова Н.Б., Вертий О.А., Корниенко В.В. Особенности диагностики болезни Бехчета. Украинский ревматологический журнал. 2013; 51(1): 96-9. http://www.rheumatology.kiev.ua/article/magazine/51
  5. Tan E., Chua S.H., Lim J.T. Retrospective study of Behcet’s disease seen at the National Skin Centre, Singapore. Ann. Acad. Med. Singapore. 1999; 28(3): 440-4.
  6. Zouboulis C.C., Kötter I., Djawari D., Kirch W., Kohl P.K., Ochsendorf F.R. et al. Epidemiological features of Adamantiades-Behcet’s disease in Germany and in Europe. Yonsei Med. J. 1997; 38(6): 411-22.
  7. Gul A., Inanc M., Ocal L., Aral O., Konice M. Familial aggregation of Behcet’s disease in Turkey. Ann. Rheum. Dis. 2000; 59(8): 622-5.
  8. Bang D.S., Oh S.H., Lee K.H., Lee E.S., Lee S.N. Influence of sex on patients with Behcet’s disease in Korea. J. Korean Med. Sci. 2003; 18(2): 231-5.
  9. Tursen U., Gurler A., Boyvat A. Evaluation of clinical findings according to sex in 2313 Turkish patients with Behcet’s disease. Int. J. Dermatol. 2003; 42(5): 346-51.
  10. Мирсаидова М.А., Раджабова Ю.Н. Иммуногенетические аспекты болезни Бехчета. Дерматовенерология и эстетическая медицина. 2016; (3-4): 5-8. https://dermatology.uz/images/jurnal/2016/DERMATOLOGIYA_N_3-4_2016.pdf
  11. Park Y.E., Cheon J.H. Updated treatment strategies for intestinal Behcet’s disease. Korean J. Intern. Med. 2018; 33(1): 1-19. doi: 10.3904/kjim.2017.377.
  12. Puccetti A., Pelosi A., Fiore P.F., Patuzzo G., Lunardi C., Dolcino M. MicroRNA expression profiling in Behcet’s disease. J. Immunol. Res. 2018; 2018: 2405150. doi: 10.1155/2018/2405150
  13. Direskeneli H. Behcet’s disease: infectious aetiology, new autoantigens, and HLA-B51. Ann. Rheum. Dis. 2001; 60(11): 996-1002. doi: 10.1136/ard.60.11.996.

Statistics

Views

Abstract - 51

PDF (Russian) - 0

Cited-By


Article Metrics

Metrics Loading ...

PlumX

Dimensions


Copyright (c) 2019 Porsokhonova D.F., Novoselov V.S., Yakubovich A.I., Mirsaidova M.A., Radzhabova Y.N., Maximov I.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies